Loading…
Achieve Life Sciences, Inc. is projected to rise to $7.69 by 2027, a +26% move from its current price of $6.11. ACHV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.89 | $6.12 | $6.35 | +0.09% |
| Jul 14 | $5.81 | $6.12 | $6.45 | +0.17% |
| Jul 15 | $5.74 | $6.13 | $6.53 | +0.26% |
| Jul 16 | $5.69 | $6.13 | $6.61 | +0.35% |
| Jul 17 | $5.65 | $6.14 | $6.67 | +0.44% |
| Jul 18 | $5.61 | $6.14 | $6.73 | +0.53% |
| Jul 19 | $5.57 | $6.15 | $6.78 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.57 | $6.15 | $6.78 | +0.61% |
| Week 2 | $5.38 | $6.19 | $7.11 | +1.23% |
| Week 3 | $5.25 | $6.22 | $7.38 | +1.85% |
| Week 4 | $5.14 | $6.26 | $7.62 | +2.48% |
| Week 5 | $5.05 | $6.30 | $7.85 | +3.11% |
| Week 6 | $4.98 | $6.34 | $8.07 | +3.74% |
| Week 7 | $4.91 | $6.38 | $8.28 | +4.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Achieve Life Sciences, Inc. is a late-stage pharmaceutical company focused on cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.
It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences is headquartered in Bothell, Washington.
The stock is currently priced at $6.23 and has a market cap of $639.57M. It is ranked 2728.
The price outlook is bullish over the long term, with forecasts showing upside beyond the near term. The 2026 average is $6.23, climbing to higher levels by 2030 and reaching an average of $163.86 by 2050.
A major floor 56.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.6% below — buyers have tended to step in here.
The nearest ceiling, 6.9% above — a clean break opens room to run.
A major ceiling 22.9% above — clearing it would confirm fresh momentum.
Key ACHV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACHV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.34 | Sell | $6.27 | Sell |
| MA 10 | $6.33 | Sell | $6.18 | Sell |
| MA 20 | $5.84 | Buy | $5.93 | Buy |
| MA 50 | $5.35 | Buy | $5.41 | Buy |
| MA 100 | $4.65 | Buy | $4.97 | Buy |
| MA 200 | $4.54 | Buy | $4.55 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.23 | Neutral |
| Stoch RSI (14) | 40.61 | Neutral |
| CCI (20) | 37.02 | Neutral |
| Williams %R (14) | -27.63 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 21.96 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 72.37 | Neutral |
| TRIX (15) | 0.84 | Buy |
| Awesome (5,34) | 0.80 | Buy |
| Ultimate (7,14,28) | 45.79 | Neutral |
| Momentum (10) | 0.41 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 6.27 | Sell |
| ADX (14) | 21.13 | Buy |
| ATR (14) | 0.20 | Info |
The 30 day technical picture shows bullish sentiment with RSI(14) at 70. The 50 day simple moving average is $5.01 and the 200 day simple moving average is $4.41, providing near term support near $4.45 and resistance at $6.23.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.65 | $6.11 | $9.01 | 0% | Neutral | |
| $5.92 | $7.69 | $10.69 | +26% | Bullish | |
| $8.66 | $11.71 | $17.08 | +92% | Bullish | |
| $10.90 | $15.24 | $23.07 | +149% | Bullish | |
| $11.26 | $16.21 | $25.31 | +165% | Bullish | |
| $13.50 | $19.98 | $32.04 | +227% | Bullish | |
| $14.02 | $21.28 | $34.96 | +248% | Bullish | |
| $13.99 | $21.75 | $36.51 | +256% | Bullish | |
| $16.24 | $25.84 | $44.24 | +323% | Bullish | |
| $18.68 | $30.40 | $53.00 | +397% | Bullish | |
| $28.16 | $50.80 | $95.59 | +731% | Bullish | |
| $60.82 | $132.36 | $277.73 | +20.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.65 | $6.11 | $7.74 | +0.00% |
| August 2026 | $5.65 | $6.74 | $8.30 | +10.34% |
| September 2026 | $5.50 | $6.62 | $8.27 | -1.85% |
| October 2026 | $5.47 | $6.64 | $8.41 | +0.39% |
| November 2026 | $5.70 | $6.96 | $8.90 | +4.84% |
| December 2026 | $5.67 | $6.98 | $9.01 | +0.21% |
Click any year to see its month-by-month ACHV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ACHV could reach as high as $9.01, with a base case around $6.11 and support toward $2.65 — roughly 0% from $6.11. A consolidation phase looks the most probable path here.
Expect ACHV to range from $5.92 to $10.69 through 2027. The $7.69 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Momentum favours further upside here.
The ACHV price prediction for 2028 points to an average of $11.71 (low $8.66, high $17.08) — a potential gain of +92% on today's $6.11. Buyers look set to stay in control over this stretch.
In 2029, ACHV is projected to trade between $10.90 and $23.07, averaging $15.24 — a potential gain of +149% from today's $6.11. That is up +30% on the projected 2028 average. Momentum favours further upside here.
Achieve Life Sciences, Inc.'s 2030 outlook centres on $16.21, within a $11.26 to $25.31 range. That is up +6% on the projected 2029 average. That marks a +165% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ACHV could reach as high as $32.04, with a base case around $19.98 and support toward $13.50 — roughly +227% from $6.11. Momentum favours further upside here.
Expect ACHV to range from $14.02 to $34.96 through 2032. The $21.28 average target implies a +248% move from current prices. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ACHV price prediction for 2033 points to an average of $21.75 (low $13.99, high $36.51) — a potential gain of +256% on today's $6.11. Momentum favours further upside here.
In 2034, ACHV is projected to trade between $16.24 and $44.24, averaging $25.84 — a potential gain of +323% from today's $6.11. That is up +19% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Achieve Life Sciences, Inc.'s 2035 outlook centres on $30.40, within a $18.68 to $53.00 range. That is up +18% on the projected 2034 average. That marks a +397% change versus current levels. Momentum favours further upside here.
By 2040, ACHV could reach as high as $95.59, with a base case around $50.80 and support toward $28.16 — roughly +731% from $6.11. Buyers look set to stay in control over this stretch.
Expect ACHV to range from $60.82 to $277.73 through 2050. The $132.36 average target implies a +20.7x move from current prices. That is up +161% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ACHV today (≈ 163.666121 ACHV) could be worth
$21,663.28
+$20,663.28 (+2066%) by 2050 · US Dollar
Based on the average projected ACHV price of $132.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACHVwould be worth at today's price.
$1,000 invested in ACHV on Jul 10, 2025 (≈ 429.184563 ACHV) would be worth
$2,622.32
+$1,622.32 (+162.2%) today · 2.62× · US Dollar
Based on a ACHV entry price of $2.33 vs. today's $6.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.4 | $954.69 | -4.5% |
| 1 month ago | $5.75 | $1,062.61 | +6.3% |
| 3 months ago | $3.49 | $1,750.72 | +75.1% |
| 6 months ago | $5.66 | $1,079.51 | +8.0% |
| 1 year ago | $2.33 | $2,622.32 | +162.2% |
| All time (5.0y) ago | $7.9 | $773.42 | -22.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACHV forecast.
Our base-case forecast reaches $12.00 around 2029.
Implied market cap at $12.00: $1.23B
Forecasts portray strong long term upside. By 2027 the average price is $8.24 with a 32.3% ROI and bullish sentiment. By 2030 the average is $18.14 with a 191.1% ROI. The 2040 forecast shows an average of $60.86 with an 877% ROI, and by 2050 the average could reach $163.86 with a 2530.2% ROI.
These figures reflect ongoing bullish sentiment through 2050, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast shows an average price of $18.14 with a minimum of $12.14 and a maximum of $29.35, and an estimated ROI of 191.1% with a bullish sentiment.
Forecasts indicate bullish sentiment across the longer horizon, with averages rising to $18.14 by 2030 and $163.86 by 2050, and ROIs up to 2530.2% in 2050. These are estimates, not guarantees.
The 2040 maximum is $120.65 and the 2050 maximum is $365.20, with a 2040 average of $60.86 and an 877% ROI. A $100 level could be approached by 2040–2050 according to the projections.
The current price is $6.23 and the market cap is $639.57M.
The 30-day range is $4.71 to $8.24, RSI(14) is 70, SMA50 is $5.01, SMA200 is $4.41, with support at $4.45 and resistance at $6.23, and the sentiment is bullish.
Achieve Life Sciences, Inc. Community Discussion
0Share your Achieve Life Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.